The FTC is not anti-direct selling. It’s pro-truth in advertising.
The DSA misses the mark.
Lomedico et al. v. American Behavioral Research Institute LLC, d/b/a Relaxium
22-cv-6097, S.D.N.Y.
(July 2022)
Relaxium
Misleadingly marketing that the supplement is a “clinically proven” sleep aid when the only scientific study conducted on the product was inadequate and sponsored by Relaxium
Falsely advertising that the supplement was developed by a “sleep expert” when he has no experience or background in treating sleep disorders
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.
Lawsuit pokes holes in company’s Swiss branding.
Why are these airport vendors slyly charging consumers for “employee benefits”?